Rouses Point, NY, United States of America

Frederick O Gemmill, Jr


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Frederick O Gemmill, Jr.

Introduction

Frederick O Gemmill, Jr. is a notable inventor based in Rouses Point, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease and bone health. With a total of 3 patents to his name, Gemmill's work has the potential to impact many lives.

Latest Patents

One of his latest patents is for .DELTA.9(11)-dehydro-8-isoestrone, which is used to treat Alzheimer's disease. This invention focuses on the use of 8.alpha.-3-hydroxyestra-1,3,5(10),9(11)tetraen-17-one (.DELTA.9(11)-dehydro-8-isoestrone) or a pharmaceutically acceptable salt thereof. Another significant patent involves modifying bone resorption with the same compound, which relates to its preparation, pharmaceutical compositions, and its use for balancing bone production and resorption, as well as serving as an antioxidant in a host animal, including humans.

Career Highlights

Frederick O Gemmill, Jr. has worked with American Home Products Corporation, where he has been able to apply his innovative ideas in a corporate setting. His work has contributed to advancements in medical treatments and has garnered attention in the pharmaceutical industry.

Collaborations

Throughout his career, Gemmill has collaborated with notable coworkers such as Chester E Orzech and Steven Jay Adelman. These partnerships have likely enhanced the development and implementation of his innovative ideas.

Conclusion

Frederick O Gemmill, Jr. is a distinguished inventor whose work in pharmaceuticals has the potential to make a significant difference in the treatment of Alzheimer's disease and bone health. His contributions continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…